Back to search

Novel Therapeutic Strategies in the Treatment of Sepsis

Data up to Jan 2025

Published1996
Citations38
References15

Total Citations Per Year

Abstract

References (15)

Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

1972 • 3,187 citations

Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli

1982 • 1,062 citations

Treatment of E. Coli and Klebsiella Bacteremia in Agranulocytic Animals with Antiserum to a UDP-GAL Epimerase-Deficient Mutant

1973 • 216 citations

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1979 • 205 citations

Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

1972 • 197 citations

A Proposed Mechanism for Natural Immunity to Enterobacterial Pathogens

1968 • 188 citations

Selective modification of aspartic acid-101 in lysozyme by carbodiimide reaction

1981 • 108 citations

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group.

1992 • 80 citations

Immunotherapy with Antibodies to Core Lipopolysaccharide: A Critical Appraisal

1991 • 61 citations

The Efficacy of Combination Immunotherapy in Experimental Pseudomonas Sepsis

1993 • 56 citations

Affinity-Purified Escherichia Coli J5 Lipopolysaccharide-Specific Igg Protects Neutropenic Rats Against Gram-Negative Bacterial Sepsis

1994 • 43 citations

Oral Ciprofloxacin and a Monoclonal Antibody to Lipopolysaccharide Protect Leukopenic Rats from Lethal Infection with Pseudomonas aeruginosa

1989 • 43 citations

118 TREATMENT OF SEVERE INFECTIOUS PURPURA IN CHILDREN WILL HUMAN PLASMA FROM DONORS IMMUNIZED WITH ESCHERICHILA COLI JS: A PROSPECTIVE, DOUBLE BLIND STUDY

1991 • 28 citations

Human Vaccination with Escherichia coli J5 Mutant Induces Cross-Reactive Bactericidal Antibody against Neisseria gonorrhoeae Lipooligosaccharide

1992 • 18 citations

Lipopolysaccharide Heterogeneity in Escherichia coli J5 Variants: Analysis by Flow Cytometry

1992 • 16 citations

Cited By (0)

Loading...
Novel Therapeutic Strategies in the Treatment of Sepsis (1996) | Metascience Observatory Explorer